Skip to main content

Lentigo

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Galderma
GaldermaTX - Dallas
1 program
1
Triple combination creamPhase 21 trial
Active Trials
NCT00975312Completed22Est. Feb 2009
Pierre Fabre
Pierre FabreFrance - Aignan
1 program
D-Pigment rich textureN/A1 trial
Active Trials
NCT03457246Completed40Est. Jun 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GaldermaTriple combination cream
Pierre FabreD-Pigment rich texture

Clinical Trials (2)

Total enrollment: 62 patients across 2 trials

NCT00975312GaldermaTriple combination cream

Solar Lentigines Treatment With the Triple Combination Cream

Start: Aug 2008Est. completion: Feb 200922 patients
Phase 2Completed
NCT03457246Pierre FabreD-Pigment rich texture

Efficacy and Tolerance of D-pigment Versus Moisturizer in Hands' Lentigo Lesions With or Without Laser Therapy

Start: May 2013Est. completion: Jun 201440 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.